The objective of this study was to test the activity of microbicides against herpes simplex virus type 2 (HSV-2) introduced in seminal plasma. We found that seminal plasma interfered with the activity of PRO 2000 and of cellulose sulfate, increasing by 100-fold the concentration of drug required to inhibit 90% of viral plaque formation. Seminal plasma competitively inhibited binding of the microbicides to the HSV-2 envelope. Most of the interference was found in a high molecular-weight fraction; tandem mass spectrometry identified the proteins as fibronectin-1 and lactoferrin. In a murine model, the interference translated in vivo into a loss in protection. We found that 2% PRO 2000 gel protected 100% of mice challenged intravaginally with HSV-2 introduced in PBS, whereas only 55% of mice were protected if virus was introduced in seminal plasma (P=.0007, log rank test). If these findings are reflective of what occurs in humans, modifications to microbicides to ensure that they retain activity in the presence of seminal plasma are indicated. © 2007 by the Infectious Diseases Society of America. All rights reserved.
CITATION STYLE
Patel, S., Hazrati, E., Cheshenko, N., Galen, B., Yang, H., Guzman, E., … Keller, M. J. (2007). Seminal plasma reduces the effectiveness of topical polyanionic microbicides. Journal of Infectious Diseases, 196(9), 1394–1402. https://doi.org/10.1086/522606
Mendeley helps you to discover research relevant for your work.